dacarbazine has been researched along with Parkinson Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harrison, C | 1 |
Biedermann, T; Chou, MT; Djapri, C; Hadi, R; Huang, B; Jang, J; Krantz, DE; Lam, HA; Lawal, HO; Lawless, GM; Maidment, NT; Roberts, L; Shahi, V; Terrell, A | 1 |
Esteguy, M; Leiguarda, R; Merello, M; Perazzo, F | 1 |
3 other study(ies) available for dacarbazine and Parkinson Disease
Article | Year |
---|---|
Patent watch.
Topics: Antineoplastic Agents, Alkylating; Antiparkinson Agents; Benzothiazoles; Brain Neoplasms; Dacarbazine; Humans; Parkinson Disease; Patents as Topic; Pramipexole; Temozolomide; Time Factors | 2010 |
Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depression.
Topics: Animals; Animals, Genetically Modified; Antiparkinson Agents; Dacarbazine; Drosophila melanogaster; Drosophila Proteins; Drug Evaluation, Preclinical; Female; Fertility; Larva; Locomotion; Male; Mutation; Parkinson Disease; Pergolide; Synapses; Vesicular Monoamine Transport Proteins | 2014 |
Impaired levodopa response in Parkinson's disease during melanoma therapy.
Topics: Adult; Dacarbazine; Dopamine; Drug Interactions; Humans; Levodopa; Male; Melanins; Melanoma; Parkinson Disease; Skin Neoplasms | 1992 |